BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8744593)

  • 1. Evolution and current status of neurotoxicity risk assessment.
    Tilson HA
    Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration Proposed Guidelines for Neurotoxicological Testing of Food Chemicals.
    Sobotka TJ; Ekelman KB; Slikker W; Raffaele K; Hattan DG
    Neurotoxicology; 1996; 17(3-4):825-36. PubMed ID: 9086506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining neurotoxicity in a decision-making context.
    Tilson HA; MacPhail RC; Crofton KM
    Neurotoxicology; 1995; 16(2):363-75. PubMed ID: 7566695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
    Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
    Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative memory disorders: a potential role of environmental toxins.
    Caban-Holt A; Mattingly M; Cooper G; Schmitt FA
    Neurol Clin; 2005 May; 23(2):485-521. PubMed ID: 15757794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative approaches to human risk assessment for noncancer health effects.
    Kimmel CA
    Neurotoxicology; 1990; 11(2):189-98. PubMed ID: 2234540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers of neurotoxic effects induced by environmental chemicals].
    Indulski JA; Lutz W
    Med Pr; 1996; 47(4):383-91. PubMed ID: 8847985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to risk assessment.
    Simonsen L; Lund SP; Hass U
    Neurotoxicology; 1996; 17(3-4):815-24. PubMed ID: 9086505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPA's neurotoxicity risk assessment guidelines.
    Boyes WK; Dourson ML; Patterson J; Tilson HA; Sette WF; MacPhail RC; Li AA; O'Donoghue JL
    Fundam Appl Toxicol; 1997 Dec; 40(2):175-84. PubMed ID: 9441713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicology dose/response assessment for several cholinesterase inhibitors: use of uncertainty factors.
    Raffaele KC; Rees C
    Neurotoxicology; 1990; 11(2):237-56. PubMed ID: 2234543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The US EPA reference dose for methylmercury: sources of uncertainty.
    Rice DC
    Environ Res; 2004 Jul; 95(3):406-13. PubMed ID: 15220074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The U.S. Environmental Protection Agency's inhalation RfD methodology: risk assessment for air toxics.
    Jarabek AM; Menache MG; Overton JH; Dourson ML; Miller FJ
    Toxicol Ind Health; 1990 Oct; 6(5):279-301. PubMed ID: 1670284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. Environmental Protection Agency procedures and policies to estimate risk of injury to the male reproductive system.
    Francis EZ
    Prog Clin Biol Res; 1989; 302():3-16; discussion 17-20. PubMed ID: 2755956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pyrethroids on voltage-sensitive calcium channels: a critical evaluation of strengths, weaknesses, data needs, and relationship to assessment of cumulative neurotoxicity.
    Shafer TJ; Meyer DA
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):303-18. PubMed ID: 15081275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.